Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 9/20 | 0.38 |
| ▸ | CA1 | P00915 | 7/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 7/20 | 0.34 |
| ▸ | CA9 | Q16790 | 6/20 | 0.34 |
| ▸ | CTSK | P43235 | 4/20 | 0.33 |
| ▸ | CTSS | P25774 | 3/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7365846 | 0.80 | MEN1 (0.36) | CA12CA1CA14CA7SYK | |
| SCHEMBL27711551 | 0.79 | MEN1 (0.45) | CA12CA1CA14CA7SYK | |
| SCHEMBL7416221 | 0.78 | CYP1A2 (0.43) | CA12CA1CA7SYKMEN1 | |
| SCHEMBL7416225 | 0.78 | CYP1A2 (0.43) | CA12CA1CA7SYKMEN1 | |
| SCHEMBL8127521 | 0.78 | CYP1A2 (0.43) | CA12CA1CA7SYKMEN1 | |
| SCHEMBL1854219 | 0.78 | MEN1 (0.44) | CA12CA1CA14CA7SYK | |
| SCHEMBL584353 | 0.78 | MEN1 (0.44) | CA12CA1CA14CA7SYK | |
| SCHEMBL2837530 | 0.78 | MEN1 (0.44) | CA12CA1CA14CA7SYK | |
| Hydrochloric Acid SCHEMBL3894157 | 0.78 | MEN1 (0.44) | CA12CA1CA14CA7SYK | |
| Hydrochloric Acid SCHEMBL23575089 | 0.76 | MEN1 (0.42) | CA12CA1CA14CA7SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996038426-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |